Covered Call Analyzer from Investment Enhancing Systems, Inc.

Close Window

Buy 500 shares of SINOVAC BIOTECH LTD (SVA) at $8.88 (closing last trade price) and sell 5 call Out-of-the-Money contracts of SVA JV (Oct$12.50) at $0.35 (closing bid price) expiring on 10/17/2009. Cost is $4,460, and income from sale of the calls is $158 and includes your commissions. Annualized return if called is 550%.
Comments:	Exercised get-out price at $7.55 (-15%) on October 2 after buying back calls at $0.05. Final value including sale of all calls is $3,890, down (12.8%).
Buy 300 shares of VANDA PHARMACEUTICALS (VNDA) at $12.59 (closing last trade price) and sell 3 call Out-of-the-Money contracts of QDX JW (Oct$17.50) at $0.65 (closing bid price) expiring on 10/17/2009. Cost is $3,797, and income from sale of the calls is $181 and includes your commissions. Annualized return if called is 542%.
Comments:	Exercised get-out price at $10.70 (-15%) on October 2 after buying back calls at $0.05. Final value including sale of all calls is $3,361, down (11.5%).
Buy 600 shares of SPECTRUM PHARMACEUTICALS (SPPI) at $7.18 (closing last trade price) and sell 6 call Out-of-the-Money contracts of QBV JB (Oct$10.00) at $0.30 (closing bid price) expiring on 10/17/2009. Cost is $4,328, and income from sale of the calls is $161 and includes your commissions. Annualized return if called is 533%.
Comments:	Exercised get-out price at $6.10 (-15%) on October 9 after buying back calls at $0.05. Final value including sale of all calls is $3,772, down (12.8%).
Buy 800 shares of MATRIXX INITIATIVES INC (MTXX) at $5.72 (closing last trade price) and sell 8 call Out-of-the-Money contracts of IHU JU (Oct$7.50) at $0.35 (closing bid price) expiring on 10/17/2009. Cost is $4,596, and income from sale of the calls is $258 and includes your commissions. Annualized return if called is 455%.
Comments:	Not called on October 17. Sold all shares at $5.56 to close out position on October 17. Final value including sale of all calls is $4,706, up 2.4%.
Buy 400 shares of BIOCRYST PHARMACEUTICALS (BCRX) at $10.02 (closing last trade price) and sell 4 call Out-of-the-Money contracts of BIU JV (Oct$12.50) at $0.80 (closing bid price) expiring on 10/17/2009. Cost is $4,028, and income from sale of the calls is $304 and includes your commissions. Annualized return if called is 399%.
Comments:	Exercised get-out price at $8.52 (-15%) on September 20 after buying back calls at $0.05. Final value including sale of all calls is $3,676, down (8.7%).
Buy 600 shares of ALLOS THERAPEUTICS INC. (ALTH) at $8.04 (closing last trade price) and sell 6 call Out-of-the-Money contracts of QAT JB (Oct$10.00) at $0.35 (closing bid price) expiring on 10/17/2009. Cost is $4,844, and income from sale of the calls is $191 and includes your commissions. Annualized return if called is 350%.
Comments:	Exercised get-out price at $6.83 (-15%) on oCTOBER 13 after buying back calls at $0.05. Final value including sale of all calls is $4,240, down (1257%).
Buy 300 shares of VANDA PHARMACEUTICALS (VNDA) at $12.59 (closing last trade price) and sell 3 call Out-of-the-Money contracts of QDX JC (Oct$15.00) at $1.15 (closing bid price) expiring on 10/17/2009. Cost is $3,797, and income from sale of the calls is $331 and includes your commissions. Annualized return if called is 343%.
Comments:	Exercised get-out price at $10.70 (-15%) on October2 after buying back calls at $0.05. Final value including sale of all calls is $3,511, down (7.5%).
Buy 700 shares of ONCOTHYREON INC (ONTY) at $6.34 (closing last trade price) and sell 7 call Out-of-the-Money contracts of KKQ JU (Oct$7.50) at $0.40 (closing bid price) expiring on 10/17/2009. Cost is $4,458, and income from sale of the calls is $260 and includes your commissions. Annualized return if called is 297%.
Comments:	Exercised get-out price at $5.39 (-15%) on September 20 after buying back calls at $0.05. Final value including sale of all calls is $3,977, down (10.8%).
Buy 700 shares of PONIARD PHARMACEUTICALS (PARD) at $7.06 (closing last trade price) and sell 7 call Out-of-the-Money contracts of FQR JU (Oct$7.50) at $1.05 (closing bid price) expiring on 10/17/2009. Cost is $4,962, and income from sale of the calls is $715 and includes your commissions. Annualized return if called is 254%.
Comments:	Not called on October 17. Sold all shares at $6.87 to close out position on October 17. Final value including sale of all calls is $5,524, up 11.3%.
Buy 500 shares of SINOVAC BIOTECH LTD (SVA) at $8.88 (closing last trade price) and sell 5 call Out-of-the-Money contracts of SVA JB (Oct$10.00) at $0.75 (closing bid price) expiring on 10/17/2009. Cost is $4,460, and income from sale of the calls is $358 and includes your commissions. Annualized return if called is 253%.
Comments:	Exercised get-out price at $7.55 (-15%) on October 2 after buying back calls at $0.05. Final value including sale of all calls is $4,090, down (8.3%).
Buy 700 shares of SOLARFUN POWER HLDGS ADR (SOLF) at $6.43 (closing last trade price) and sell 7 call Out-of-the-Money contracts of QFG JU (Oct$7.50) at $0.25 (closing bid price) expiring on 10/17/2009. Cost is $4,521, and income from sale of the calls is $155 and includes your commissions. Annualized return if called is 246%.
Comments:	Exercised get-out price at $5.47 (-15%) on October 1 after buying back calls at $0.05. Final value including sale of all calls is $3,928, down (13.1%).
Buy 500 shares of MGIC INVESTMENTS CORP (MTG) at $8.76 (closing last trade price) and sell 5 call Out-of-the-Money contracts of MTG JB (Oct$10.00) at $0.55 (closing bid price) expiring on 10/17/2009. Cost is $4,400, and income from sale of the calls is $258 and includes your commissions. Annualized return if called is 245%.
Comments:	Exercised get-out price at $7.45 (-15%) on September 30 after buying back calls at $0.05. Final value including sale of all calls is $3,940, down (10.5%).
Buy 500 shares of AMR CORP (AMR) at $8.65 (closing last trade price) and sell 5 call Out-of-the-Money contracts of AMR JB (Oct$10.00) at $0.40 (closing bid price) expiring on 10/17/2009. Cost is $4,345, and income from sale of the calls is $183 and includes your commissions. Annualized return if called is 243%.
Comments:	Exercised get-out price at $7.35 (-15%) on October 1 after buying back calls at $0.05. Final value including sale of all calls is $3,815, down (12.2%).
Buy 500 shares of OREXIGEN THERAPEUTICS (OREX) at $8.97 (closing last trade price) and sell 5 call Out-of-the-Money contracts of QRF JB (Oct$10.00) at $0.45 (closing bid price) expiring on 10/17/2009. Cost is $4,505, and income from sale of the calls is $208 and includes your commissions. Annualized return if called is 196%.
Comments:	Not called on October 17. Sold all shares at $8.59 to close out position on October 17. Final value including sale of all calls is $4,503, down (0.1%).
Buy 700 shares of HERCULES OFFSHORE INC (HERO) at $6.74 (closing last trade price) and sell 7 call Out-of-the-Money contracts of HIQ JU (Oct$7.50) at $0.30 (closing bid price) expiring on 10/17/2009. Cost is $4,738, and income from sale of the calls is $190 and includes your commissions. Annualized return if called is 186%.
Comments:	Exercised get-out price at $5.73 (-15%) on September 20 after buying back calls at $0.05. Final value including sale of all calls is $4,145, down (12.5%).
Buy 600 shares of SPECTRUM PHARMACEUTICALS (SPPI) at $7.18 (closing last trade price) and sell 6 call Out-of-the-Money contracts of QBV JU (Oct$7.50) at $0.80 (closing bid price) expiring on 10/17/2009. Cost is $4,328, and income from sale of the calls is $461 and includes your commissions. Annualized return if called is 184%.
Comments:	Exercised get-out price at $6.10 (-15%) on October 9 after buying back calls at $0.05. Final value including sale of all calls is $4,072, down (5.9%).
Buy 600 shares of ZALE CORP (ZLC) at $7.16 (closing last trade price) and sell 6 call Out-of-the-Money contracts of ZLC JU (Oct$7.50) at $0.75 (closing bid price) expiring on 10/17/2009. Cost is $4,316, and income from sale of the calls is $431 and includes your commissions. Annualized return if called is 179%.
Comments:	Not called on October 17. Sold all shares at $7.63 to close out position on October 17. Final value including sale of all calls is $4,911, up 13.8%.
Buy 500 shares of JAZZ PHARMACEUTICALS INC (JAZZ) at $9.50 (closing last trade price) and sell 5 call Out-of-the-Money contracts of JWQ JB (Oct$10.00) at $0.80 (closing bid price) expiring on 10/17/2009. Cost is $4,770, and income from sale of the calls is $383 and includes your commissions. Annualized return if called is 162%.
Comments:	Exercised get-out price at $8.08 (-15%) on October 1 after buying back calls at $0.05. Final value including sale of all calls is $4,380, down (8.2%).
Buy 300 shares of MECHEL OAO (MTL) at $16.18 (closing last trade price) and sell 3 call Out-of-the-Money contracts of MTL JW (Oct$17.50) at $0.85 (closing bid price) expiring on 10/17/2009. Cost is $4,874, and income from sale of the calls is $241 and includes your commissions. Annualized return if called is 159%.
Comments:	Called on October 17 at $17.50. Total return including call premium is $5,471, up 12.2%.
Buy 700 shares of THQ INC (THQI) at $6.60 (closing last trade price) and sell 7 call Out-of-the-Money contracts of QHI JU (Oct$7.50) at $0.25 (closing bid price) expiring on 10/17/2009. Cost is $4,640, and income from sale of the calls is $155 and includes your commissions. Annualized return if called is 208%.
Comments:	Not called on October 17. Sold all shares at $5.62 to close out position on October 17. Final value including sale of all calls is $4,089, down (11.9%).
Income from sale of calls is +$5,576
All positions closed out on October 17. Cost of these ten (20) stocks is $89,166 . At October 17, 2009 (expiration weekend), this list value is $84,001, down (5.8%). The NASDAQ was up 1.1% for the period this list was open.

*After the effect of all commissions.
The stocks listed above are for illustrative and educational purposes only and should not be construed as an endorsement, recommendation, or solicitation to buy or sell any particular security.